Contrast-enhancement of the anterior eye segment in patients with retinoblastoma: Correlation between clinical, MR imaging, and histopathologic findings

American Journal of Neuroradiology

Volumn 31, Issue 2, 2010, Pages 237-245

  De Graaf, Pim ^a   Van Der Valk, P ^a   Moll, A C ^a   Imhof, S M ^a   Schouten van Meeteren, A Y N ^b   Knol, D L ^a   Castelijns, J A ^a  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^b EMMA CHILDREN S HOSPITAL   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

CD31 ANTIGEN; GADOLINIUM PENTETATE; VASCULOTROPIN; VASCULOTROPIN RECEPTOR 1;

ANTERIOR EYE SEGMENT; ANTIGEN DETECTION; ANTIGEN EXPRESSION; ARTICLE; CANCER INVASION; CANCER PATIENT; CANCER TISSUE; CHILD; CHOROIDITIS; CLINICAL ARTICLE; CONTRAST ENHANCEMENT; CONTROLLED STUDY; ENUCLEATION; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; HYPEREMIA; IMAGE ANALYSIS; IMMUNOHISTOCHEMISTRY; INFANT; INTRAOCULAR PRESSURE; MALE; NECROSIS; NUCLEAR MAGNETIC RESONANCE IMAGING; OPTIC NERVE; PRESCHOOL CHILD; PROTEIN DETERMINATION; PROTEIN EXPRESSION; RETINA BLOOD VESSEL; RETINA DETACHMENT; RETINOBLASTOMA; SCORING SYSTEM; TUMOR LOCALIZATION; TUMOR RECURRENCE; TUMOR VOLUME;

ANTERIOR CHAMBER; ANTIGENS, CD31; BIOPSY; CHILD, PRESCHOOL; CONTRAST MEDIA; EYE ENUCLEATION; EYE NEOPLASMS; FEMALE; FOLLOW-UP STUDIES; HUMANS; IMMUNOHISTOCHEMISTRY; INFANT; MAGNETIC RESONANCE IMAGING; MALE; NEOVASCULARIZATION, PATHOLOGIC; RETINOBLASTOMA; RETROSPECTIVE STUDIES; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-1;

EID: 76749098879     PISSN: 01956108     EISSN: None     Source Type: Journal    
DOI: 10.3174/ajnr.A1825     Document Type: Article

References (34)

1. Lumbroso-Le Rouic L, Aerts I, Levy-Gabriel C, et al. Conservative treatments of intraocular retinoblastoma. Ophthalmology 2008;115:1405-10
2. Chantada GL, Dunkel IJ, Antoneli CB, et al. Risk factors for extraocular relapse following enucleation after failure of chemoreduction in retinoblastoma. Pediatr Blood Cancer 2007;49:256-60
3. Chantada GL, Casco F, Fandino AC, et al. Outcome of patients with retinoblastoma and postlaminar optic nerve invasion. Ophthalmology 2007;114:2083-89
4. Uusitalo MS, Van Quill KR, Scott IU, et al. Evaluation of chemoprophylaxis in patients with unilateral retinoblastoma with high-risk features on histopathologic examination. Arch Ophthalmol 2001;119:41-48
5. Schueler AO, Hosten N, Bechrakis NE, et al. High resolution magnetic resonance imaging of retinoblastoma. Br J Ophthalmol 2003;87:330-35
6. de Graaf P, Barkhof F, Moll AC, et al. Retinoblastoma:MRimaging parameters in detection of tumor extent. Radiology 2005;235:197-207
7. Lemke AJ, Kazi I, Mergner U, et al. Retinoblastoma: MR appearance using a surface coil in comparison with histopathological results. Eur Radiol 2007;17:49-60
8. Brisse HJ, Guesmi M, Aerts I, et al. Relevance of CT and MRI in retinoblastoma for the diagnosis of postlaminar invasion with normal-size optic nerve: a retrospective study of 150 patients with histological comparison. Pediatr Radiol 2007;37:649-56
9. Marback EF, Arias VE, Paranhos A Jr, et al. Tumour angiogenesis as a prognostic factor for disease dissemination in retinoblastoma. Br J Ophthalmol 2003;87:1224-28
10. Rossler J, Dietrich T, Pavlakovic H, et al. Higher vessel densities in retinoblastoma with local invasive growth and metastasis. Am J Pathol 2004;164:391-94
11. Jockovich ME, Suarez F, Alegret A, et al. Mechanism of retinoblastoma tumor cell death after focal chemotherapy, radiation, and vascular targeting therapy in a mouse model. Invest Ophthalmol Vis Sci 2007;48:5371-76
12. Pe'er J, Neufeld M, Baras M, et al. Rubeosis iridis in retinoblastoma: histologic findings and the possible role of vascular endothelial growth factor in its induction. Ophthalmology 1997;104:1251-58
13. Kvanta A, Steen B, Seregard S. Expression of vascular endothelial growth factor (VEGF) in retinoblastoma but not in posterior uveal melanoma. Exp Eye Res 1996;63:511-18
14. Stitt AW, Simpson DA, Boocock C, et al. Expression of vascular endothelial growth factor (VEGF) and its receptors is regulated in eyes with intra-ocular tumours. J Pathol 1998;186:306-12
15. Kuchle M, Vinores SA, Green WR. Immunohistochemical evaluation of the integrity of the blood-aqueous barrier in normal and rubeotic human eyes. Graefes Arch Clin Exp Ophthalmol 1995;233:414-20
16. Miller JW, Adamis AP, Shima DT, et al. Vascular endothelial growth factor/vascular permeability factor is temporally and spatially correlated with ocular angiogenesis in a primate model. Am J Pathol 1994;145:574-84
17. Tolentino MJ, Miller JW, Gragoudas ES, et al. Vascular endothelial growth factor is sufficient to produce iris neovascularization and neovascular glaucoma in a nonhuman primate. Arch Ophthalmol 1996;114:964-70
18. Galluzzi P, Cerase A, Hadjistilianou T, et al. Retinoblastoma: abnormal gadolinium enhancement of anterior segment of eyes at MR imaging with clinical and histopathologic correlation. Radiology 2003;228:683-90. Epub 2003 Jul 24
19. Landis JR, Koch GG. The measurement of observer agreement for categorical data. Biometrics 1977;33:159-74
20. Freddo TF. Shifting the paradigm of the blood-aqueous barrier. Exp Eye Res 2001;73:581-92
21. Bert RJ, Caruthers SD, Jara H, et al. Demonstration of an anterior diffusional pathway for solutes in the normal human eye with high spatial resolution contrast-enhanced dynamic MR imaging. Invest Ophthalmol Vis Sci 2006;47:5153-62
22. Bert R, Freddo T, Caruthers SD, et al. Confirmation of an anterior large-molecule diffusion pathway in the normal human eye. Invest Ophthalmol Vis Sci 1999;40(suppl):S198
23. Chen CJ. Intraocular contrast enhancement in Adams pattern III hypoxic brain damage: MRI. Neuroradiology 2000;42:54-55
24. Kerbel R, Folkman J. Clinical translation of angiogenesis inhibitors. Nat Rev Cancer 2002;2:727-39
25. Penn JS, Madan A, Caldwell RB, et al. Vascular endothelial growth factor in eye disease. Prog Retin Eye Res 2008;27:331-71
26. Ferrara N. Vascular endothelial growth factor: basic science and clinical progress. Endocr Rev 2004;25:581-611
27. Vermeulen PB, Gasparini G, Fox SB, et al. Second international consensus on the methodology and criteria of evaluation of angiogenesis quantification in solid human tumours. Eur J Cancer 2002;38:1564-79
28. Ino-ue M, Azumi A, Shirabe H, et al. Iridopathy in eyes with proliferative diabetic retinopathy: detection of early stage of rubeosis iridis. Ophthalmologica 1998;212:15-18
29. Imhof BA, Aurrand-Lions M. Angiogenesis and inflammation face off. Nat Med 2006;12:171-72
30. Matsubayashi R, Matsuo Y, Edakuni G, et al. Breast masses with peripheral rim enhancement on dynamic contrast-enhanced MR images: correlation of MR findings with histologic features and expression of growth factors. Radiology 2000;217:841-48
31. Teraoka H, Sawada T, Nishihara T, et al. Enhanced VEGF production and decreased immunogenicity induced by TGF-beta 1 promote liver metastasis of pancreatic cancer. Br J Cancer 2001;85:612-17
32. Brancato R, Bandello F, Lattanzio R. Iris fluorescein angiography in clinical practice. Surv Ophthalmol 1997;42:41-70
33. Rebeles F, Fink J, Anzai Y, et al. Blood-brain barrier imaging and therapeutic potentials. Top Magn Reson Imaging 2006;17:107-16
34. Jubb AM, Oates AJ, Holden S, et al. Predicting benefit from anti-angiogenic agents in malignancy. Nat Rev Cancer 2006;6:626-35